Extra Corporeal Membrane Oxygenation (ECMO) Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Description
Growth Factors of Extra Corporeal Membrane Oxygenation (ECMO) Market
The Extra Corporeal Membrane Oxygenation (ECMO) market is experiencing steady growth globally, driven by the rising prevalence of cardiovascular and respiratory diseases and the increasing adoption of advanced life-support technologies. According to Fortune Business Insights, the global ECMO market was valued at approximately USD 532.3 million in 2024 and is projected to reach USD 716.5 million by 2032, exhibiting a compound annual growth rate (CAGR) of around 3.8% during the forecast period from 2025 to 2032.
Understanding ECMO and Its Clinical Importance
ECMO is a critical life-support technique used primarily for patients suffering from severe cardiac or respiratory failure. It works by oxygenating the blood outside the patient’s body, allowing the heart and lungs to rest and heal. This technology is especially vital in cases such as acute respiratory distress syndrome (ARDS), cardiogenic shock, cardiac arrest, and during complex cardiac surgeries.
The significance of ECMO was particularly underscored during the COVID-19 pandemic, where its application surged for patients with severe respiratory failure. The pandemic brought widespread attention to ECMO as an essential tool for critical care, especially in intensive care units (ICUs) treating COVID-19-induced ARDS. This surge has translated into sustained interest and investment in ECMO technologies worldwide.
Market Segmentation: Type and Application
The ECMO market is broadly segmented into two types: Veno-Arterial (VA) ECMO and Veno-Venous (VV) ECMO. VA ECMO, which supports both heart and lung function, holds the larger market share in 2024. It is commonly used in cardiac patients, including infants with congenital heart defects and adults recovering from heart transplants or cardiac arrest.
On the other hand, VV ECMO is primarily used to support lung function and has witnessed the fastest growth recently, owing to its crucial role in managing severe respiratory conditions. Its increasing adoption was further accelerated during the COVID-19 crisis, where it demonstrated improved survival rates compared to traditional ventilation methods alone.
By application, the market is divided into adult, pediatric, and neonatal ECMO. The adult segment dominates the market, driven by the high prevalence of cardiovascular diseases and respiratory disorders in this demographic. The pediatric segment is growing as well, propelled by congenital heart diseases and pneumonia cases in children. The neonatal segment, while smaller due to technical challenges and risks, remains vital for newborns with critical heart and lung conditions.
Regional Insights
North America is the leading regional market, accounting for nearly 49% of the global ECMO market share in 2024. The region benefits from advanced healthcare infrastructure, high cardiovascular disease incidence, and widespread ECMO adoption in critical care centers across the United States and Canada.
Europe follows with steady growth, supported by strong healthcare investments, technological advancements, and favorable reimbursement policies. Asia-Pacific is identified as the fastest-growing region, driven by increasing healthcare spending, expanding ECMO centers, and a rising patient population suffering from chronic respiratory and cardiac conditions.
Other regions like Latin America and the Middle East & Africa (MEA) are also gradually increasing their market presence as healthcare infrastructure improves and ECMO awareness grows.
Technological Advancements and Market Drivers
The ECMO market is witnessing rapid technological innovation that is improving device usability and patient outcomes. Developments include miniaturized circuits, advanced oxygenators, and the introduction of portable ECMO systems that enable long-term patient mobility. Notable examples include magnetic levitation pumps that reduce blood damage and oxygenators with enhanced biocompatibility.
These advancements, combined with rising cardiovascular and respiratory disease incidence, are driving market expansion. Additionally, the growing geriatric population worldwide further fuels demand for ECMO, as older adults are more susceptible to chronic heart and lung diseases.
Market Challenges
Despite its growth potential, the ECMO market faces certain hurdles. The high cost of ECMO equipment and consumables, typically ranging between USD 35,000 and 48,000 per treatment, limits accessibility, especially in developing countries. Moreover, ECMO is a highly complex procedure involving risks such as bleeding, thrombosis, infections, and neurological complications, requiring highly skilled medical teams and specialized training.
Competitive Landscape
The ECMO market is highly consolidated, dominated by leading medical device manufacturers such as Getinge AB, Terumo Corporation, Medtronic, LivaNova, and ABIOMED. These companies are actively investing in product development, regulatory approvals, and strategic acquisitions to expand their product portfolios and market reach. For instance, LivaNova's acquisition of ALung Technologies and ABIOMED’s acquisition of Breethe underscore industry consolidation and innovation trends.
Conclusion
The global ECMO market is poised for steady growth over the next decade, propelled by increasing demand for life-support solutions, technological innovations, and expanding healthcare infrastructure globally. While cost and procedural complexity remain challenges, continuous advancements in ECMO technology and broader awareness among healthcare providers are expected to improve accessibility and outcomes, ultimately driving market expansion through 2032.
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2024
Forecast Period 2025-2032
Historical Period 2019-2023
Growth Rate CAGR of 3.8% from 2025-2032
Unit Value (USD million)
Segmentation By Type, Application, and Region
By Type Veno-Arterial
Veno-Venous
By Application
Adult
Pediatric
Neonatal
By Region North America (By Type, By Application, By Country)
U.S.
Canada
Europe (By Type, By Application, By Country/Sub-region)
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Type, By Application, By Country/Sub-region)
China
Japan
India
Australia
Southeast Asia
Rest of Asia Pacific
Latin America (By Type, By Application, By Country/Sub-region)
Brazil
Mexico
Rest of Latin America
Middle East and Africa (By Type, By Application, By Country/Sub-region)
South Africa
GCC
Rest of Middle East and Africa
Please Note:
It will take 5-6 business days to complete the report upon order confirmation.
The Extra Corporeal Membrane Oxygenation (ECMO) market is experiencing steady growth globally, driven by the rising prevalence of cardiovascular and respiratory diseases and the increasing adoption of advanced life-support technologies. According to Fortune Business Insights, the global ECMO market was valued at approximately USD 532.3 million in 2024 and is projected to reach USD 716.5 million by 2032, exhibiting a compound annual growth rate (CAGR) of around 3.8% during the forecast period from 2025 to 2032.
Understanding ECMO and Its Clinical Importance
ECMO is a critical life-support technique used primarily for patients suffering from severe cardiac or respiratory failure. It works by oxygenating the blood outside the patient’s body, allowing the heart and lungs to rest and heal. This technology is especially vital in cases such as acute respiratory distress syndrome (ARDS), cardiogenic shock, cardiac arrest, and during complex cardiac surgeries.
The significance of ECMO was particularly underscored during the COVID-19 pandemic, where its application surged for patients with severe respiratory failure. The pandemic brought widespread attention to ECMO as an essential tool for critical care, especially in intensive care units (ICUs) treating COVID-19-induced ARDS. This surge has translated into sustained interest and investment in ECMO technologies worldwide.
Market Segmentation: Type and Application
The ECMO market is broadly segmented into two types: Veno-Arterial (VA) ECMO and Veno-Venous (VV) ECMO. VA ECMO, which supports both heart and lung function, holds the larger market share in 2024. It is commonly used in cardiac patients, including infants with congenital heart defects and adults recovering from heart transplants or cardiac arrest.
On the other hand, VV ECMO is primarily used to support lung function and has witnessed the fastest growth recently, owing to its crucial role in managing severe respiratory conditions. Its increasing adoption was further accelerated during the COVID-19 crisis, where it demonstrated improved survival rates compared to traditional ventilation methods alone.
By application, the market is divided into adult, pediatric, and neonatal ECMO. The adult segment dominates the market, driven by the high prevalence of cardiovascular diseases and respiratory disorders in this demographic. The pediatric segment is growing as well, propelled by congenital heart diseases and pneumonia cases in children. The neonatal segment, while smaller due to technical challenges and risks, remains vital for newborns with critical heart and lung conditions.
Regional Insights
North America is the leading regional market, accounting for nearly 49% of the global ECMO market share in 2024. The region benefits from advanced healthcare infrastructure, high cardiovascular disease incidence, and widespread ECMO adoption in critical care centers across the United States and Canada.
Europe follows with steady growth, supported by strong healthcare investments, technological advancements, and favorable reimbursement policies. Asia-Pacific is identified as the fastest-growing region, driven by increasing healthcare spending, expanding ECMO centers, and a rising patient population suffering from chronic respiratory and cardiac conditions.
Other regions like Latin America and the Middle East & Africa (MEA) are also gradually increasing their market presence as healthcare infrastructure improves and ECMO awareness grows.
Technological Advancements and Market Drivers
The ECMO market is witnessing rapid technological innovation that is improving device usability and patient outcomes. Developments include miniaturized circuits, advanced oxygenators, and the introduction of portable ECMO systems that enable long-term patient mobility. Notable examples include magnetic levitation pumps that reduce blood damage and oxygenators with enhanced biocompatibility.
These advancements, combined with rising cardiovascular and respiratory disease incidence, are driving market expansion. Additionally, the growing geriatric population worldwide further fuels demand for ECMO, as older adults are more susceptible to chronic heart and lung diseases.
Market Challenges
Despite its growth potential, the ECMO market faces certain hurdles. The high cost of ECMO equipment and consumables, typically ranging between USD 35,000 and 48,000 per treatment, limits accessibility, especially in developing countries. Moreover, ECMO is a highly complex procedure involving risks such as bleeding, thrombosis, infections, and neurological complications, requiring highly skilled medical teams and specialized training.
Competitive Landscape
The ECMO market is highly consolidated, dominated by leading medical device manufacturers such as Getinge AB, Terumo Corporation, Medtronic, LivaNova, and ABIOMED. These companies are actively investing in product development, regulatory approvals, and strategic acquisitions to expand their product portfolios and market reach. For instance, LivaNova's acquisition of ALung Technologies and ABIOMED’s acquisition of Breethe underscore industry consolidation and innovation trends.
Conclusion
The global ECMO market is poised for steady growth over the next decade, propelled by increasing demand for life-support solutions, technological innovations, and expanding healthcare infrastructure globally. While cost and procedural complexity remain challenges, continuous advancements in ECMO technology and broader awareness among healthcare providers are expected to improve accessibility and outcomes, ultimately driving market expansion through 2032.
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2024
Forecast Period 2025-2032
Historical Period 2019-2023
Growth Rate CAGR of 3.8% from 2025-2032
Unit Value (USD million)
Segmentation By Type, Application, and Region
By Type Veno-Arterial
Veno-Venous
By Application
Adult
Pediatric
Neonatal
By Region North America (By Type, By Application, By Country)
U.S.
Canada
Europe (By Type, By Application, By Country/Sub-region)
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Type, By Application, By Country/Sub-region)
China
Japan
India
Australia
Southeast Asia
Rest of Asia Pacific
Latin America (By Type, By Application, By Country/Sub-region)
Brazil
Mexico
Rest of Latin America
Middle East and Africa (By Type, By Application, By Country/Sub-region)
South Africa
GCC
Rest of Middle East and Africa
Please Note:
It will take 5-6 business days to complete the report upon order confirmation.
Table of Contents
125 Pages
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Number of Heart and Lung Transplantations, By Key Countries, 2024
- 4.2. New Product Launches
- 4.3. Key Industry Developments – Key Mergers, Acquisitions and Partnerships
- 4.4. Impact of COVID-19 on the Extracorporeal Membrane Oxygenation (ECMO) Machine Market
- 5. Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Type
- 5.1.1. VA (Veno-Arterial) ECMO Machine
- 5.1.2. VV (Veno-Venous) ECMO Machine
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Adult
- 5.2.2. Pediatric
- 5.2.3. Neonatal
- 5.3. Market Analysis, Insights and Forecast – By Geography
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Latin America
- 5.3.5. Middle East & Africa
- 6. North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Type
- 6.1.1. VA (Veno-Arterial) ECMO Machine
- 6.1.2. VV (Veno-Venous) ECMO Machine
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. Adult
- 6.2.2. Pediatric
- 6.2.3. Neonatal
- 6.3. Market Analysis, Insights and Forecast – By Country
- 6.3.1. U.S.
- 6.3.2. Canada
- 7. Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Type
- 7.1.1. VA (Veno-Arterial) ECMO Machine
- 7.1.2. VV (Veno-Venous) ECMO Machine
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. Adult
- 7.2.2. Pediatric
- 7.2.3. Neonatal
- 7.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 7.3.1. U.K.
- 7.3.2. Germany
- 7.3.3. France
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Scandinavia
- 7.3.7. Rest of Europe
- 8. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Type
- 8.1.1. VA (Veno-Arterial) ECMO Machine
- 8.1.2. VV (Veno-Venous) ECMO Machine
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. Adult
- 8.2.2. Pediatric
- 8.2.3. Neonatal
- 8.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. India
- 8.3.4. South Korea
- 8.3.5. Australia
- 8.3.6. Southeast Asia
- 8.3.7. Rest of Asia Pacific
- 9. Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Type
- 9.1.1. VA (Veno-Arterial) ECMO Machine
- 9.1.2. VV (Veno-Venous) ECMO Machine
- 9.2. Market Analysis, Insights and Forecast – By Application
- 9.2.1. Adult
- 9.2.2. Pediatric
- 9.2.3. Neonatal
- 9.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 9.3.1. Brazil
- 9.3.2. Mexico
- 9.3.3. Rest of Latin America
- 10. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast – By Type
- 10.1.1. VA (Veno-Arterial) ECMO Machine
- 10.1.2. VV (Veno-Venous) ECMO Machine
- 10.2. Market Analysis, Insights and Forecast – By Application
- 10.2.1. Adult
- 10.2.2. Pediatric
- 10.2.3. Neonatal
- 10.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 10.3.1. GCC
- 10.3.2. South Africa
- 10.3.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2024)
- 11.2. Profiles of Players Operating in the Market (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (based on availability))
- 11.2.1. Getinge AB
- 11.2.1.1. Overview,
- 11.2.1.2. Products,
- 11.2.1.3. SWOT Analysis,
- 11.2.1.4. Recent Developments,
- 11.2.1.5. Strategies,
- 11.2.1.6. financials (based on availability)
- 11.2.2. LivaNova PLC
- 11.2.2.1. Overview,
- 11.2.2.2. Products,
- 11.2.2.3. SWOT Analysis,
- 11.2.2.4. Recent Developments,
- 11.2.2.5. Strategies,
- 11.2.2.6. financials (based on availability)
- 11.2.3. Xenios AG (Fresenius Medical Care)
- 11.2.3.1. Overview,
- 11.2.3.2. Products,
- 11.2.3.3. SWOT Analysis,
- 11.2.3.4. Recent Developments,
- 11.2.3.5. Strategies,
- 11.2.3.6. financials (based on availability)
- 11.2.4. EUROSETS
- 11.2.4.1. Overview,
- 11.2.4.2. Products,
- 11.2.4.3. SWOT Analysis,
- 11.2.4.4. Recent Developments,
- 11.2.4.5. Strategies,
- 11.2.4.6. financials (based on availability)
- 11.2.5. ABIOMED
- 11.2.5.1. Overview,
- 11.2.5.2. Products,
- 11.2.5.3. SWOT Analysis,
- 11.2.5.4. Recent Developments,
- 11.2.5.5. Strategies,
- 11.2.5.6. financials (based on availability)
- 11.2.6. Medtronic
- 11.2.6.1. Overview,
- 11.2.6.2. Products,
- 11.2.6.3. SWOT Analysis,
- 11.2.6.4. Recent Developments,
- 11.2.6.5. Strategies,
- 11.2.6.6. financials (based on availability)
- 11.2.7. NIPRO
- 11.2.7.1. Overview,
- 11.2.7.2. Products,
- 11.2.7.3. SWOT Analysis,
- 11.2.7.4. Recent Developments,
- 11.2.7.5. Strategies,
- 11.2.7.6. financials (based on availability)
- 11.2.8. Spectrum Medical
- 11.2.8.1. Overview,
- 11.2.8.2. Products,
- 11.2.8.3. SWOT Analysis,
- 11.2.8.4. Recent Developments,
- 11.2.8.5. Strategies,
- 11.2.8.6. financials (based on availability)
- 11.2.9. Terumo Corporation
- 11.2.9.1. Overview,
- 11.2.9.2. Products,
- 11.2.9.3. SWOT Analysis,
- 11.2.9.4. Recent Developments,
- 11.2.9.5. Strategies,
- 11.2.9.6. financials (based on availability)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
